Featured Stories

Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.

Rajni Chauhan

For 30 years, Rajni Chauhan struggled with migraines, visiting numerous doctors and clinics, but …

Manish Gupta

The experiences of people battling pancreatitis vary, but everyone eventually reaches a ‘Pa…

Keshav Agrawal

My name is Keshav Agarwal, and I live in Kashipur. My life took a serious turn in 2013 when I was…

Raj Khanapara

Rajkot, Gujarat, India — For Raj Khanapara, a 26-year-old businessman from Rajkot, the onse…




Rajkot, Gujarat

Ved Hitendra Kumar Vyas

Ahmedabad, India — At 18, Ved Hitendra Kumar Vyas, an engineering student from Ahmedabad, w…




Ahmedabad, Gujarat

Pankaj Giri

People who have faced pancreatitis have their own experiences, but the common thread in their sto…

All Stories

Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.

Surendra Rathaur

Surendra Rathaur

Acute Pancreatitis




Ahmedabad, Gujarat

Ahmedabad, Gujarat, India — Surendra Rathaur, a 34-year-old Senior Software Engineer from A…

Samip Desai

Samip Desai

Chronic Calcific Pancreatitis




Ahmedabad, Gujarat

Ahmedabad, Gujarat, India — Samip Desai, a 38-year-old restaurateur from Ahmedabad, embarke…

Hardi Nayak

Hardi Nayak

Acute Pancreatitis




Gandhinagar, Gujarat

Gandhinagar, Gujarat, India — Hardi Nayak, a 12-year-old student from Gandhinagar, found he…

Raj Khanapara

Raj Khanapara

Chronic Pancreatitis




Rajkot, Gujarat

Rajkot, Gujarat, India — For Raj Khanapara, a 26-year-old businessman from Rajkot, the onse…

Ajay Vaghela

Ajay Vaghela

Recurrent Acute Pancreatitis




Ahmedabad, Gujarat

Ahmedabad, Gujarat, India — For Ajay Vaghela, a 30-year-old petrol pump business owner from…

Aditya Jain

Aditya Jain

Acute on Chronic Pancreatitis




Ahmedabad, Gujarat

Ahmedabad, Gujarat, India — At the age of 15, Aditya Jain, a student from Ahmedabad, faced …

Our Research

At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.

Observational research on the effect of an Ayurvedic treatment protocol in patients of hereditary pancreatitis

Observational research on the effect of an Ayurvedic treatment protocol in patients of hereditary pancreatitis

Hereditary pancreatitis (HP) is a chronic genetic disorder with limited treatment options. This study evaluated the efficacy of a year-long Ayurvedic Treatment Protocol (ATP) in 151 patients, 88 of whom completed the program. The treatment included Ayurvedic formulations, dietary adjustments, and discontinuation of pancreatic enzymes. Results showed a 92.8% reduction in attack frequency and a 98.7% decrease in hospitalizations (p < 0.0001), with no adverse effects. ATP demonstrated safety and effectiveness in managing HP, suggesting the need for further research.

Symptom-free status after prolonged suffering with refractory chronic migraine: A case report

Symptom-free status after prolonged suffering with refractory chronic migraine: A case report

A 37-year chronic refractory migraine sufferer experienced significant relief in pain, symptoms, and overall well-being after nine months of Ayurvedic treatment, highlighting its potential therapeutic benefits.

Anti-Inflammatory Properties of a Processed Copper Complex in L-Arginine Induced Pancreatitis-Two Experimental Studies

Anti-Inflammatory Properties of a Processed Copper Complex in L-Arginine Induced Pancreatitis-Two Experimental Studies

Recurrent Acute/Chronic Pancreatitis (RA/CP) is a progressive pancreatic inflammation, often with unclear causes. An Ayurvedic Mineral Complex (AMC) showed promise in reducing exacerbations and hospitalizations in pancreatitis patients. In a rat model, AMC was well tolerated, reduced oxidative stress and inflammation, and protected the pancreas at doses of 25 mg/kg and 19 mg/kg.

Integration of Ayurvedic formulations with iron folic acid in the treatment of nutritional anaemia among school going adolescents of Dehradun District

Integration of Ayurvedic formulations with iron folic acid in the treatment of nutritional anaemia among school going adolescents of Dehradun District

This study evaluated the effect of Ayurvedic preparations Sootshekhar Rasa (SR) and Sitopaladi Churna (SC) with iron and folic acid (IFA) on nutritional anaemia in 820 adolescents in Dehradun, India. After 90 days of treatment, all groups showed increased haemoglobin levels, with the best results in the group receiving SR + SC + IFA. No major side effects were reported, and the treatment led to sustainable improvements in anaemia.

Demographic Pattern of Pancreatitis Patients in India – A Hospital-based Study

Demographic Pattern of Pancreatitis Patients in India – A Hospital-based Study

A hospital-based study on 2,050 pancreatitis patients across India found that 83% were male, with an average age of 24 years, and 75% aged between 19–45. Alcohol use was reported by 33.6% and tobacco by 18.4%, while genetic and gallstone-related causes accounted for 8.8% and 5% respectively. The findings suggest emerging lifestyle and regional risk factors, but broader studies are needed for definitive insights.

Proof of Efficacy Study to Evaluate an Ayurvedic Formulation in the Treatment of Allergic Rhinitis: An Open Label Randomized Controlled Clinical Trial

Proof of Efficacy Study to Evaluate an Ayurvedic Formulation in the Treatment of Allergic Rhinitis: An Open Label Randomized Controlled Clinical Trial

A study on 250 patients compared the Ayurvedic formulation IMMBO to a levocetirizine-montelukast combination for allergic rhinitis. IMMBO showed significantly greater improvements in symptoms (TNSS: -5.70 vs. -3.31) and IgE reduction (-351.54 vs. -208.79), demonstrating superior efficacy and safety.